CD8A and neoplasm: Others have reported that the ratio of CD8/Tregs can be used as a marker for successful anti-tumor response to immunotherapy.17 Most importantly, HuM1 CD8+ T-cells did not display an increase following anti-PD-1, indicating possible CD8+ T-cell dysfunction or anergy in HuM1 mice (Supplementary Figure 1A).